Page last updated: 2024-10-25

deferoxamine and Plasmacytoma

deferoxamine has been researched along with Plasmacytoma in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Plasmacytoma: Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hammersley, PA1

Other Studies

1 other study available for deferoxamine and Plasmacytoma

ArticleYear
Relative tumour enhancement of 67Ga uptake by desferrioxamine.
    European journal of nuclear medicine, 1984, Volume: 9, Issue:10

    Topics: Animals; Deferoxamine; Gallium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantat

1984